News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Filippo Pietrantonio: Vorbipiprant with PD-1 Blockade for Refractory MSS Metastatic Colorectal Cancer
Filippo Pietrantonio/X
Dec 4, 2024, 06:28

Filippo Pietrantonio: Vorbipiprant with PD-1 Blockade for Refractory MSS Metastatic Colorectal Cancer

Filippo Pietrantonio, GI medical oncologist at the National Cancer Institute of Milan, shared a post on X about a recent paper by him and colleagues published in Clinical Cancer Research:

“The Prostaglandin EP4 Antagonist Vorbipiprant Combined with PD-1 Blockade for Refractory Microsatellite Stable Metastatic Colorectal Cancer: A Phase 1b/2a Trial.”

Authors: Filippo Pietrantonio, Federica Morano, Monica Niger, Federica Girolami, Lucio Rovati et al.

Filippo Pietrantonio: Vorbipiprant with PD-1 Blockade for Refractory MSS Metastatic Colorectal Cancer

More posts featuring Filippo Pietrantonio.

cancer Federica Girolami Federica Morano Filippo Pietrantonio Lucio Rovati Metastatic colorectal cancer Monica Niger OncoDaily Oncology Vorbipiprant
Special Coverage
Blog
Jan 6, 2025, 16:00
Lazar Popovic: Inviting you to the 14th Novi Sad Oncology Congress
Blog
Jan 6, 2025, 15:59
Nelson Dusetti: Thrilled to visit IRCCS Ospedale San Raffaele
Blog
Jan 6, 2025, 15:56
Aman Chauhan: I had a fantastic time working with AJCC on the Latest NET staging
Insight
Jan 6, 2025, 15:49
Talha Badar: DDX41mt predisposition syndrome in myeloid neoplasms
Science
Jan 6, 2025, 15:47
Moazzam Shahzad: Exploring allo-HCT outcomes in geriatric patients
Science
Jan 6, 2025, 15:06
Ali Nabavizadeh: The link between radiomics and immunological traits in pediatric low-grade glioma
Science
Jan 6, 2025, 15:04
Patrick Hwu: How can we make cancer vaccines more effective?
Science
Jan 6, 2025, 15:02
Shernan G. Holtan: New findings from the Blood and Marrow Transplant Clinical Trials Network 1703 trial
Opinion
Jan 6, 2025, 14:59
Breakthroughs in immunotherapy by Steven O’Day and Alexander Eggermont
Blog
Jan 6, 2025, 14:53
Amol Akhade: Should oncologist treat own 1st and 2nd degree relatives themselves?
Blog
Jan 6, 2025, 14:52
Senthil Kumar: From Shadows to Solutions - The Revolution Against Cancer
Science
Jan 6, 2025, 14:48
Gustavo Viani: Prophylactic Pelvic RT with SBRT for High-Risk node negative Prostate Cancer